Search results

Search for "nanostructured lipid carriers" in Full Text gives 8 result(s) in Beilstein Journal of Nanotechnology.

Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals

  • Selin Akpinar Adscheid,
  • Akif E. Türeli,
  • Nazende Günday-Türeli and
  • Marc Schneider

Beilstein J. Nanotechnol. 2024, 15, 1400–1414, doi:10.3762/bjnano.15.113

Graphical Abstract
  • ; intranasal delivery; liposomes; nanomedicine; nanostructured lipid carriers (NLCs); polymer nanoparticles; RNA delivery; solid lipid nanoparticles (SLNs); Introduction The central nervous system (CNS) consists of the brain and the spinal cord and is considered the body’s processing and control center. While
  • situ esculin-loaded nanoliposomes for intranasal administration for treating Parkinson’s disease. Ex vivo studies further confirmed the enhanced permeation of the nanoliposomal formulation compared to the suspension form by approximately 40% [99]. Solid lipid NPs and nanostructured lipid carriers Solid
  • the low drug loading capacity and drug expulsion during storage because of an increased crystallization tendency [102]. Researchers developed a second generation of lipid-based drug carriers called nanostructured lipid carriers (NLCs). Unlike the SLNs, the core structure of the NLCs is composed of
PDF
Album
Review
Published 12 Nov 2024

Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review

  • Douglas Dourado,
  • Thayse Silva Medeiros,
  • Éverton do Nascimento Alencar,
  • Edijane Matos Sales and
  • Fábio Rocha Formiga

Beilstein J. Nanotechnol. 2024, 15, 37–50, doi:10.3762/bjnano.15.4

Graphical Abstract
  • higher. In vivo studies demonstrated that the nanoformulations were more effective in reducing parasitemia in the spleen, with results equivalent to the group treated with amphotericin B. Das and collaborators, on the other hand, addressed the development of nanostructured lipid carriers (NLC) with
  • (SNEDDSs), (ii) nanoliposomes, (iii) nanostructured lipid carriers, (iv) polymeric, and (v) metallic nanoparticles. Different performances of nanostructured systems containing curc are discussed in the section below. Self-nanoemulsifying drug-delivery systems The SNEDDSs are lipid-based drug-delivery
  • following the Ambisome® path. Nanostructured lipid carriers Nanostructured lipid carriers (NLCs) are lipid-based formulations with a solid matrix at room temperature that differ from solid lipid nanoparticles when it comes to their matrix organizational level. Nanostructured lipid carriers offer advantages
PDF
Album
Review
Published 04 Jan 2024

Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies

  • Giuliana Muraca,
  • María Esperanza Ruiz,
  • Rocío C. Gambaro,
  • Sebastián Scioli-Montoto,
  • María Laura Sbaraglini,
  • Gisel Padula,
  • José Sebastián Cisneros,
  • Cecilia Yamil Chain,
  • Vera A. Álvarez,
  • Cristián Huck-Iriart,
  • Guillermo R. Castro,
  • María Belén Piñero,
  • Matias Ildebrando Marchetto,
  • Catalina Alba Soto,
  • Germán A. Islan and
  • Alan Talevi

Beilstein J. Nanotechnol. 2023, 14, 804–818, doi:10.3762/bjnano.14.66

Graphical Abstract
  • in the chronic stage, possibly because current treatment regimens do not eradicate transiently dormant Trypanosoma cruzi amastigotes. Nanostructured lipid carriers (NLC) appear to be a promising approach for delivering pharmaceutical active ingredients as they can have a positive impact on
  • . These results show potential for the development of new nanomedicines against T. cruzi. Keywords: benznidazole; biopharmaceutical study; Chagas disease; nanoparticles; nanostructured lipid carriers; physicochemical characterization; Trypanosoma cruzi; Introduction Chagas disease is a neglected disease
  • development of nanostructured lipid carriers (NLC) [20]. Here, we resort to NLC encapsulating BNZ, describing the preparation, physicochemical and biopharmaceutical characterization, and in vitro evaluation against T. cruzi intracellular and blood circulating forms. Interestingly, our formulation achieves a
PDF
Album
Supp Info
Full Research Paper
Published 28 Jul 2023

Nanotechnology – a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer

  • Filip Gorachinov,
  • Fatima Mraiche,
  • Diala Alhaj Moustafa,
  • Ola Hishari,
  • Yomna Ismail,
  • Jensa Joseph,
  • Maja Simonoska Crcarevska,
  • Marija Glavas Dodov,
  • Nikola Geskovski and
  • Katerina Goracinova

Beilstein J. Nanotechnol. 2023, 14, 240–261, doi:10.3762/bjnano.14.23

Graphical Abstract
PDF
Album
Review
Published 22 Feb 2023

Use of nanosystems to improve the anticancer effects of curcumin

  • Andrea M. Araya-Sibaja,
  • Norma J. Salazar-López,
  • Krissia Wilhelm Romero,
  • José R. Vega-Baudrit,
  • J. Abraham Domínguez-Avila,
  • Carlos A. Velázquez Contreras,
  • Ramón E. Robles-Zepeda,
  • Mirtha Navarro-Hoyos and
  • Gustavo A. González-Aguilar

Beilstein J. Nanotechnol. 2021, 12, 1047–1062, doi:10.3762/bjnano.12.78

Graphical Abstract
  • increased pharmacokinetics and anticancer activity when the molecule was co-loaded with resveratrol and gelucire and tested in vitro against human colon cancer HCT-116 cells [68]. Nanostructured lipid carriers (NLC). Nanostructured lipid carriers are the second generation of drug carriers. They are made up
  • of surfactants and biocompatible lipids that are solid at ambient temperature, which allows them to immobilize drugs and prevent the polymerization of particles within their matrix. Nanostructured lipid carriers have increased drug-loading capacity, as compared to the first generation of lipid-based
PDF
Album
Review
Published 15 Sep 2021

Key for crossing the BBB with nanoparticles: the rational design

  • Sonia M. Lombardo,
  • Marc Schneider,
  • Akif E. Türeli and
  • Nazende Günday Türeli

Beilstein J. Nanotechnol. 2020, 11, 866–883, doi:10.3762/bjnano.11.72

Graphical Abstract
  • brain delivery. Interestingly, in a study by Peira et al., SLNs have been successfully loaded with superparamagnetic iron oxide and were able to cross the BBB [163]. Thus, SLNs could be potentially used as carriers for CNS MRI contrast agents. Nanostructured lipid carriers: Although most of the reported
  • applications of nanostructured lipid carriers (NLCs) for brain delivery are using the intranasal pathway [164][165][166][167], some studies have shown that NLC are also able to deliver drugs to the brain through the BBB. NLC are lipid-based particles composed of a liquid lipid phase inside a solid lipid phase
PDF
Album
Review
Published 04 Jun 2020

BergaCare SmartLipids: commercial lipophilic active concentrates for improved performance of dermal products

  • Florence Olechowski,
  • Rainer H. Müller and
  • Sung Min Pyo

Beilstein J. Nanotechnol. 2019, 10, 2152–2162, doi:10.3762/bjnano.10.208

Graphical Abstract
  • inclusion; nanostructured lipid carriers (NLCs); penetration enhancement; skin occlusion; SmartLipids; solid lipid nanoparticles (SLNs); Introduction To meet the increasing expectations and demands of consumers in personal care and cosmetics, as well of patients in medical care, dermal delivery systems are
  • and therefore are solid at body temperature. The second generation of these particles, the nanostructured lipid carriers (NLCs), made it to the cosmetic market in 2005 and are typically a mixture of one solid lipid and one liquid lipid [4], e.g., tristearin and caprylic/capric triglyceride, also being
PDF
Album
Review
Published 04 Nov 2019

Lipid nanostructures for antioxidant delivery: a comparative preformulation study

  • Elisabetta Esposito,
  • Maddalena Sguizzato,
  • Markus Drechsler,
  • Paolo Mariani,
  • Federica Carducci,
  • Claudio Nastruzzi,
  • Giuseppe Valacchi and
  • Rita Cortesi

Beilstein J. Nanotechnol. 2019, 10, 1789–1801, doi:10.3762/bjnano.10.174

Graphical Abstract
  • against pollutants. Namely, solid lipid nanoparticles and nanostructured lipid carriers were prepared using different lipids (tristearin, compritol, precirol or suppocire) in the presence or absence of caprylic/capric triglycerides. The formulations were characterized by particle size analysis, cryogenic
  • transmission electron microscopy, small-angle X-ray diffraction, encapsulation efficiency, preliminary stability, in vitro cytotoxicity and protection against cigarette smoke. Nanostructured lipid carriers were found to reduce agglomerate formation and provided better dimensional stability, as compared to
  • solid lipid nanoparticles, suggesting their suitability for antioxidant loading. Based on the preformulation study, tristearin-based nanostructured lipid carriers loaded with α-tocopherol were selected for ex vivo studies since they displayed superior physico-chemical properties as compared to the other
PDF
Album
Full Research Paper
Published 29 Aug 2019
Other Beilstein-Institut Open Science Activities